To assess the role of PKM2 in sorafenib resistance in the process of HCC treatment, small interfering RNA (siRNA) and overexpressing plasmid transfection were used to, respectively, silence and overexpress PKM2 in different HCC cell lines. Here, PKM is linked to hepatocellular carcinoma.